19:15 , Jul 19, 2019 |  BC Extra  |  Financial News

July 19 Financial Quick Takes: Amarin raises cash ahead of Vascepa PDUFA date, plus Atara, Sunstone and Forendo

Ahead of Vascepa push, Amarin adds $400M to coffers  With the Sept. 28 PDUFA date looming for a potential expansion of the label for Vascepa icosapent to include reduced cardiovascular risk, Amarin Corp. plc (NASDAQ:AMRN)...
00:04 , Jul 19, 2019 |  BC Extra  |  Financial News

Genmab’s plans after $500M NASDAQ debut

European bellwether Genmab plans to use a large chunk of the $505.9 million it raised through its listing on NASDAQ Thursday to fuel clinical development and commercialization of antibody-drug conjugate tisotumab vedotin (HuMax-TF-ADC). Two other...
00:00 , Jul 12, 2019 |  BC Extra  |  Financial News

July 11 Financial Quick Takes: Illumina tumbles on revenue miss; plus PureTech, Horizon and more

Illumina falls after revenue miss  Illumina Inc. (NASDAQ:ILMN) was off $58.66 (16%) to $305 in after-hours trading after reporting preliminary 2Q19 revenues of $835 million, barely topping its $830 million revenues in the prior year’s...
21:32 , Jul 9, 2019 |  BC Extra  |  Financial News

July 9 Financial Quick Takes: ADC tops off megaround with $27M; plus Genmab, GNS, StemRIM and more

ADC closes expanded E round at $303M   ADC Therapeutics S.A. (Lausanne, Switzerland) raised an additional $27 million in its expanded series E round, which closed at $303 million. In June, the developer of antibody-drug...
23:41 , Jun 28, 2019 |  BC Extra  |  Financial News

June 28 Financial Quick Takes: Karuna rises after IPO; plus Chi-Med, BeiGene and more

Karuna spikes in first-day trading on NASDAQ  PureTech Health plc (LSE:PRTC) portfolio company Karuna Therapeutics Inc. (NASDAQ:KRTX) climbed $4.02 (25%) to $20.02 Friday after raising $89.2 million through the sale of 5.6 million shares at...
20:45 , Jun 13, 2019 |  BC Extra  |  Financial News

June 13 Financial Quick Takes: Hansoh prices $1B HKEX IPO; plus Provention, Genome Medical, InGeneron and more

Hansoh gets $10B-plus valuation via Hong Kong IPO  Hansoh Pharmaceutical Group Co. Ltd. (HKSE:03692) priced its Hong Kong IPO Thursday, raising HK$7.9 billion ($1 billion) through the sale of 551.3 million shares at HK$14.26. The...
21:11 , Jun 4, 2019 |  BC Extra  |  Financial News

June 4 Financial Quick Takes: Lung Therapeutics' $36M series C; plus Strand, Hansoh, Inhibrx and more

Lung Therapeutics closes $36M series C  Lung Therapeutics Inc. (Austin, Texas) raised $36 million in a series C round led by Bios Partners with participation by undisclosed new and existing investors. Lung has raised $53...
18:38 , Jun 2, 2019 |  BC Extra  |  Company News

Aslan’s change of course on eczema asset brings flexibility for future deals

Aslan's decision to restructure an existing deal with CSL for atopic dermatitis candidate ASLAN004, extending the partnership's scope to give the biotech full commercial rights, is part of Aslan's broader intention to gain flexibility for...
21:34 , May 28, 2019 |  BC Extra  |  Financial News

May 28 Financial Quick Takes: Alphamab Oncology raises $60M; plus $180.5M for Panacea healthcare fund and more

Hudson Bay leads Alphamab Oncology's $60M series B Alphamab Oncology (Cayman) raised $60 million in a series B round led by Hudson Bay Capital, with participation from new investor and entrepreneur Adrian Cheng and existing...
17:02 , May 23, 2019 |  BC Extra  |  Financial News

How Bicycle, Ideaya fared in debuts as they join 2019’s growing IPO class

A pair of newly listed biotechs trended in opposite directions during first-day trading Thursday. Bicycle slipped 14% after pricing its IPO at the bottom end of its proposed range, while Ideaya was up 12% after...